Bioeconomy: State of the Industry 2020

DOPE

Cannabis or cannabinoids? The cannabis story is essentially written, we’ll see more legalization and more use, but it will be niche. The hemp story is just beginning as a volume feedstock. Cannabinoids as a high-margin low volume product stream – the story is hardly underway.